Chen Liu

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 5

Top Topics

Bioinformatics Analysis

Ejection Fraction

Prognostic Factors

Top Venues

Cancer management and research

Journal of immunology research

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Yunzhen Qian, Yitao Gong, Xuan Zou, Yu Liu, Yusheng Chen, Ruijie Wang, Zhengjie Dai, Yesiboli Tasiheng, Xuan Lin, Xu Wang, Guopei Luo, Xian-Jun Yu, He Cheng, Chen Liu
Aberrant APOBEC3C expression induces characteristic genomic instability in pancreatic ductal adenocarcinoma. Oncogenesis 11 (1) (2022)
Yunzhen Qian, Yitao Gong, Yu Liu, Yusheng Chen, Ruijie Wang, Zhengjie Dai, Xuan Zou, Yesiboli Tasiheng, Guopei Luo, Xuan Lin, Xu Wang, He Cheng, Xian-Jun Yu, Chen Liu
Atypical Mucin Expression Predicts Worse Overall Survival in Resectable Pancreatic Ductal Adenocarcinoma. Journal of immunology research 2022 (2022)
Yitao Gong, Zhiyao Fan, Guopei Luo, Qiuyi Huang, Yunzhen Qian, He Cheng, Kaizhou Jin, Quanxing Ni, Xian-Jun Yu, Chen Liu
Absolute Counts of Peripheral Lymphocyte Subsets Correlate with the Progression-Free Survival and Metastatic Status of Pancreatic Neuroendocrine Tumour Patients. Cancer management and research 12 (2020)
He Cheng, Guopei Luo, Kaizhou Jin, Zhiyao Fan, Qiuyi Huang, Yitao Gong, Jin Xu, Xian-Jun Yu, Chen Liu
Kras mutation correlating with circulating regulatory T cells predicts the prognosis of advanced pancreatic cancer patients. Cancer medicine 9 (6) (2020)
Zhiyao Fan, Kun Fan, Yitao Gong, Qiuyi Huang, Chao Yang, He Cheng, Kaizhou Jin, Quanxing Ni, Xian-Jun Yu, Guopei Luo, Chen Liu
The CRP/Albumin Ratio Predicts Survival And Monitors Chemotherapeutic Effectiveness In Patients With Advanced Pancreatic Cancer. Cancer management and research 11 (2019)